Novo Nordisk has long supplied human insulin pens to the national health department. But last year it decided not to bid for ...

About 400 people marched to the South African headquarters of Novo Nordisk A/S in Johannesburg this week demanding greater ...

The addition of AI into healthcare is something that has been a controversial decision as many people believe there is still ...

In recent years, technological advancements in healthcare have revolutionised the management of chronic conditions like ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

Digital health tools, artificial intelligence (AI), and wearable devices are leading the way in transforming the landscape ...

The article provides an overview of recent developments in the healthcare sector, including Novo Nordisk's phase-out of ...

Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other ...

Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, confirming an ...

Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...